Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01672567 · ClinicalTrials.gov registry record · NA
Effects of Egg Ingestion on Endothelial Function in Adults With Coronary Artery Disease
A NA study, sponsored by Griffin Hospital.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT01672567: Completed NA study, sponsored by Griffin Hospital.
NCT01672567 is a NA study that has completed, run by Griffin Hospital. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01672567, a NA study, has completed, sponsored by Griffin Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effects of daily consumption of eggs or egg substitute for 6 weeks on endothelial function and on cholesterol and lipoprotein levels in participants with clinically established coronary heart disease (CHD).
Primary Outcome
FMD will be measured as the percent change in brachial artery diameter from pre-cuff inflation to 60-seconds post-cuff release (upper arm cuff position). In addition to brachial diameter at 60 seconds post-cuff release, flow after cuff deflation within the first 15 seconds will be used as an indicator of stimulus strength, hyperemic flow being the stimulus for endothelial reactivity.
Interventions
- DIETARY_SUPPLEMENT Egg supplementation
- DIETARY_SUPPLEMENT Egg substitute
- DIETARY_SUPPLEMENT Control diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2010-10 |
| Est. Completion | 2012-04 |
| Phase | NA |
What the finished NCT01672567 record still lists
NCT01672567 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 3 interventions - of which Egg supplementation is the first listed.
NCT01672567 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01672567 about?
NCT01672567 is a clinical study titled "Effects of Egg Ingestion on Endothelial Function in Adults With Coronary Artery Disease". The purpose of this study is to determine the effects of daily consumption of eggs or egg substitute for 6 weeks on endothelial function and on cholesterol and lipoprotein levels in participants with clinically established coronary heart disease (CHD).
What is the current status of trial NCT01672567?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2010-10. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01672567?
The interventions under investigation include: Egg supplementation (DIETARY_SUPPLEMENT), Egg substitute (DIETARY_SUPPLEMENT), Control diet (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01672567?
This trial is sponsored by Griffin Hospital, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01672567's enrollment target sits among peer trials
34 1570th of 2000 higher than 427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia